Alerts will be sent to your verified email
Verify EmailWANBURY
|
Wanbury
|
Bharat Parenterals
|
Beta Drugs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
58.3 % | 8.64 % | 22.74 % |
|
5yr average Equity Multiplier
|
-1.35 | 1.84 | 1.82 |
|
5yr Average Asset Turnover Ratio
|
1.54 | 0.73 | 1.03 |
|
5yr Avg Net Profit Margin
|
5.09 % | 5.85 % | 12.23 % |
|
Price to Book
|
16.69 | 2.68 | 4.36 |
|
P/E
|
23.02 | 0.0 | 25.18 |
|
5yr Avg Cash Conversion Cycle
|
-103.0 Days | 107.3 Days | 7.75 Days |
|
Inventory Days
|
21.96 Days | 52.36 Days | 46.07 Days |
|
Days Receivable
|
61.39 Days | 167.45 Days | 91.57 Days |
|
Days Payable
|
194.51 Days | 103.87 Days | 119.03 Days |
|
5yr Average Interest Coverage Ratio
|
2.13 | 14.58 | 14.42 |
|
5yr Avg ROCE
|
-37.9 % | 9.5 % | 27.84 % |
|
5yr Avg Operating Profit Margin
|
7.72 % | 9.16 % | 21.76 % |
|
5 yr average Debt to Equity
|
0.2 | 0.36 | 0.29 |
|
5yr CAGR Net Profit
|
n/a | n/a | 29.34 % |
|
5yr Average Return on Assets
|
7.92 % | 5.04 % | 12.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.02 % | 67.17 % | 64.63 % |
|
Share Pledged by Promoters
|
62.18 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
3.18 % | -6.67 % | -2.1 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Wanbury
|
Bharat Parenterals
|
Beta Drugs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|